Applied Therapeutics Cash Flow Statement (2023-2025) | APLT

Cash Flow Statement Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Operating Activities
Net Income -10.64M-16.77M-15.10M-20.66M-20.51M-19.81M-28.39M-32.06M-24.90M-22.73M-16.61M
Share-based Compensation 2.06M1.84M1.84M1.63M2.38M1.89M2.09M9.21M1.49M2.10M1.14M
Gains from Investment Securities -0.47M4.78M27.28M16.96M63.41M4.31M40.18M-76.06M7.06M7.66M7.62M
Non-cash Items 4.04M4.22M4.25M7.04M4.37M1.10M0.70M2.00M1.10M4.37M4.43M
Cash from Operations -6.99M-16.45M-14.73M-17.00M-18.91M-22.59M-23.33M-19.47M-28.64M-20.34M-18.40M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.11M0.12M0.12M0.01M0.12M0.12M0.10M0.08M0.10M0.11M0.11M
Change in Working Capital
Change in Account Payables 1.02M-0.87M1.32M-4.26M0.53M0.41M0.15M1.60M0.43M-0.01M-0.14M
Change in Accured Expenses -0.11M0.32M-3.03M3.55M-0.76M-3.92M3.19M2.65M-6.68M1.21M12.82M
Investing Activities
Change in Acquisitions & Divestments 8.93M
Cash from Investing Activities 13.87M
Financing Activities
Debt Issuance and Repayment
Short-Term Debt repayments 0.62M0.31M0.47M0.47M0.31M
Change in Capital Stock
Shares Issued 10.23M9.03M95.72M-95.72M0.02M
Misc.
Cash from Financing Activities -0.62M29.15M16.57M29.45M115.50M-1.69M-0.07M
Change in Cash 6.26M12.70M1.84M12.44M96.59M-24.29M-23.33M-19.47M-28.64M-20.34M-18.48M
Free Cash Flow -6.99M-16.45M-14.73M-17.00M-18.91M-22.59M-23.33M-19.47M-28.64M-20.34M-18.40M
Net Cash Flow 6.26M12.70M1.84M12.44M96.59M-24.29M-23.33M-19.47M-28.64M-20.34M-18.48M